OakChart

iSpecimen Inc

ISPCHealthcare·Diagnostics & Research·USA·Nano·NASD·Nov 11 • 12:23 PM ET

0.7001-0.0374 (-5.07%)
2026-11-11 18:43 CET
Market cap
1.86 USD m
Revenue, TTM
0.47 USD m
Net income, TTM
-11.42 USD m
Free cash flow, TTM
-7.00 USD m
EPS diluted, TTM
-50.28
P/E
-
Compare

Price

ISPC against its 20, 50 and 200-day averages
2050200
0.0010.0020.007.1M14.2MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ISPCclose 0.7020-day 0.8450-day 1.10200-day 4.300.70

97.4% under the 52-week high of 27.44 on 28 Nov 2025. 52-week low 0.64 on 11 Nov 2026. Last 15 sessions, 49.5% high to low

Profile

ISPC
52-week range, 0% of the way up
0.7127.44

iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.

Employees7
IPOJun 17, 2021
Beta1.78
ATR, 14d0.09
Rel volume0.21
Short float12.11%
Insider own0.00%
Inst own3.38%

Snapshot

6 groups

Valuation

Index-
Market Cap1.77M
Enterprise Value-2.40M
Income-11.42M
Sales0.47M
Book/sh1.14
Cash/sh1.75
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees7
IPOJun 17, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S3.76
P/B0.61
P/C0.40
P/FCF-
EV/EBITDA-
EV/Sales-5.12
Quick Ratio0.82
Current Ratio0.82
Debt/Eq0.14
LT Debt/Eq0.10
Option/ShortNo / Yes

Earnings

EPS (ttm)-50.28
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y53.84% 30.62%
Sales past 3/5Y-42.97% -25.10%
EPS Y/Y TTM86.78%
Sales Y/Y TTM-92.11%
EPS Q/Q94.17%
Sales Q/Q-78.69%
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own0.00%
Insider Trans-
Inst Own3.38%
Inst Trans379.11%
ROA-170.10%
ROE-968.47%
ROIC-596.00%
Gross Margin-355.95%
Oper. Margin-2020.04%
Profit Margin-2449.04%
SMA20-17.04%
SMA50-36.54%
SMA200-83.73%
Trades-

Technical

Shs Outstand2.52M
Shs Float2.52M
Short Float12.11%
Short Ratio0.42
Short Interest0.31M
52W High27.44 -97.45%
52W Low0.71 -1.81%
Volatility9.71% 10.10%
ATR (14)0.09
RSI (14)27.34
Beta1.78
Rel Volume0.21
Avg Volume721.16K
Volume80,025

Performance

Perf Week-16.95%
Perf Month-35.18%
Perf Quarter-69.56%
Perf Half Y-83.37%
Perf YTD-93.27%
Perf Year-97.26%
Perf 3Y-99.83%
Perf 5Y-99.98%
Perf 10Y-
Recom1.00
Target Price2400.00
Prev Close0.74
Price0.70
Change %-5.07%

Peers

Mkt cap
TickerCompanyMkt cap
AZTAAzenta Inc2.17B
CRLCharles River Laboratories International Inc16.78B
CSBRChampions Oncology Inc67.36M
IQVIQVIA Holdings Inc45.90B
BDSXBiodesix Inc123.18M
PRPOPrecipio Inc41.79M
DGXQuest Diagnostics Inc28.31B
SHCSotera Health Co4.71B
CCELCryo-Cell International Inc41.53M
FTREFortrea Holdings Inc2.05B

News

latest 14 of 206
  • iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products (Newsfile Corp.)
  • iSpecimen Offers Next-Day Healthy Donor Blood and Launches Development of AI Agent (Newsfile) -9.35%
  • iSpecimen Supports Hospital Validation of New Chemistry Analyzer (Newsfile Corp.)
  • iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks (GlobeNewswire) -25.55%
  • iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
  • Loading…
  • iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire) +14.58%
  • iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement (GlobeNewswire)
  • iSpecimen Announces 1-for-40 Reverse Stock Split (Newsfile) -19.61%
  • BC-Most Active Stocks (Associated Press) +17.17%
  • BC-Most Active Stocks (Associated Press) -9.45%
  • BC-Most Active Stocks (Associated Press)
  • iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time (Newsfile) -10.34%
  • iSpecimen Achieves Rapid Procurement Milestone for Influenza Research (Newsfile) -30.87%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2024Q32024-11-07-84.000--2562.66--
2024Q22024-08-06-152--148.782.86--
2024Q12024-05-07-256-216-254.222.292.841
2023Q42024-03-14-272-192-270.572.573.041
2023Q32023-11-02-184-280-186.32.782.241
2023Q22023-08-02-312-240-308.51.633.071
2023Q12023-05-04-216-256-216.622.952.621
2022Q42023-03-14-192-300-193.573.202.672
2022Q32022-11-08-280-272-278.932.582.452
2022Q22022-08-04-240-220-236.42.342.872
2022Q12022-05-10-216-200-217.562.522.782
2021Q22021-08-10---0.8702.90--
2024Q4---160-251.11-2.981
2025Q1---176-28.554-2.551
2025Q2---152-16.777-3.101
2025Q3---152-19.047-3.331

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-1,672-1,624-820.9111.1412.10
2022FY-928--926.7810.40-
2023FY-984-896-9849.9310.39
2024FY--704-703.26-11.08
2025FY--632-91.147-12.38

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2024Q4S2024-09-101102.982.982.98
2024Q4S2024-09-091102.982.982.98
2024Q4S2024-09-081102.982.982.98
2024Q4S2024-09-071102.982.982.98
2024Q4S2024-09-061102.982.982.98
2024Q4S2024-09-051102.982.982.98
2024Q4S2024-09-041102.982.982.98
2024Q4S2024-09-031102.982.982.98
2024Q4S2024-09-021102.982.982.98
2024Q4S2024-09-011102.982.982.98
2024Q4S2024-08-311102.982.982.98
2024Q4S2024-08-301102.982.982.98
2024Q4S2024-08-291102.982.982.98
2024Q4S2024-08-281102.982.982.98

Estimate history

EPS, annual-651.512-575.968-566.832-820.912-926.784-982.112-703.258-91.147-50.2837
Period20182019202020212022202320242025TTM
EPS, quarterly-148.776-83.817-251.106-28.554-16.777-19.047-23.595-6.665-0.977
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual4.3954.2988.18411.13510.4029.9289.2911.9290.47
Period20182019202020212022202320242025TTM
Sales, quarterly2.8642.6621.4761.0580.7130.1070.0520.1560.152
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.0080.0080.0080.0110.0110.0110.0420.2121.522
Period20182019202020212022202320242025MRQ
Shares, quarterly0.0160.0210.0420.0620.0620.2440.2120.7421.522
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.471.939.299.9310.4011.148.184.304.39
Cost of Goods Sold Incl. D&A2.133.447.416.895.966.253.592.132.36
Gross Profit-1.66-1.521.893.044.444.884.602.172.03
Selling, General and Administrative Excl. Other7.765.5914.2914.2114.6310.817.016.055.39
Research and Development1.070.942.034.603.462.411.921.791.88
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-9.42-7.11-12.40-11.17-10.19-5.93-2.41-3.88-3.36
Interest Expense3E-060.000.170.020.242.102.101.721.21
Unusual Expense0.001.870.330.000.000.900.16-0.550.95
Net Income Before Taxes-11.42-10.49-12.50-11.10-10.25-8.96-4.65-4.88-5.47
Income Taxes0.000.000.000.000.000.000.00-0.16-0.13
Consolidated Net Income-11.42-10.49-12.50-11.10-10.25-8.96-4.65-4.73-5.35
Net Income From Continuing Operations-11.42-10.49-12.50-11.10-10.25-8.96-4.65-4.73-5.35
Net Income-11.42-10.49-12.50-11.10-10.25-8.96-4.65-4.73-5.35
EPS (Recurring)-8.19-79.76-690.36-982.11-926.78-763.16-553.27-622.96-570.82
EPS (Basic, Before Extraordinaries)-50.28-91.15-703.26-982.11-926.78-820.91-566.83-575.97-651.51
EPS (Diluted)-50.28-91.15-703.26-982.11-926.78-820.91-566.83-575.97-651.51
EBITDA-8.22-5.38-10.11-9.10-8.98-4.92-1.59-3.25-2.89
Non-Operating Income (Expense)-2.00-1.510.400.090.18-0.030.010.170.04
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.000.020.250.460.680.620.070.260.08
Price To Sales Ratio7.920.620.200.461.176.13---
Gross Margin-355.95-78.5520.3030.6442.6843.8556.1950.4946.24
Operating Margin-2,020.04-368.42-133.47-112.50-97.92-53.21-29.40-90.27-76.37
Net Margin-2,449.04-543.68-134.51-111.80-98.50-80.48-56.84-109.97-121.67
Shares Outstanding1.520.210.040.010.010.010.010.010.01
Market Capitalization1.861.864.514.5412.2268.2160.53--

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.150.160.050.110.711.061.482.66
Cost of Goods Sold Incl. D&A0.280.220.960.660.881.091.822.10
Gross Profit-0.13-0.06-0.91-0.56-0.16-0.03-0.350.56
Selling, General and Administrative Excl. Other1.232.471.782.271.661.615.492.27
Research and Development0.130.150.220.570.640.640.590.84
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.36-2.54-2.69-2.83-1.82-1.64-5.84-1.71
Interest Expense0.000.001E-062E-060.000.000.160.01
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-1.36-2.28-5.00-2.78-1.05-1.66-6.05-1.44
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-1.36-2.28-5.00-2.78-1.05-1.66-6.05-1.44
Net Income From Continuing Operations-1.36-2.28-5.00-2.78-1.05-1.66-6.05-1.44
Net Income-1.36-2.28-5.00-2.78-1.05-1.66-6.05-1.44
EPS (Recurring)-0.98-6.66-23.59-19.05-16.78-28.55-251.11-83.82
EPS (Basic, Before Extraordinaries)-0.98-6.66-23.59-19.05-16.78-28.55-251.11-83.82
EPS (Diluted)-0.98-6.66-23.59-19.05-16.78-28.55-251.11-83.82
EBITDA-1.16-2.40-2.28-2.37-1.39-1.21-5.29-1.16
Non-Operating Income (Expense)0.000.26-2.310.050.77-0.02-0.050.27
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.000.000.000.000.000.020.010.07
Price To Sales Ratio7.922.091.142.250.410.310.280.31
Gross Margin-87.41-41.25-1,752.13-521.36-22.97-3.07-23.6421.23
Operating Margin-897.06-1,627.09-5,192.87-2,655.19-255.41-154.93-395.83-64.07
Net Margin-896.94-1,458.39-9,662.19-2,608.68-146.85-156.82-409.81-54.09
Shares Outstanding1.520.740.210.240.060.060.040.02
Market Capitalization1.864.662.2112.602.452.654.513.90

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments6.881.885.0115.3127.740.700.051.13
Short Term Receivables0.051.442.944.074.882.361.391.03
Inventories0.000.000.000.000.000.000.050.05
Other Current Assets0.030.260.290.300.330.420.080.10
Total Current Assets6.953.598.2419.6832.953.471.582.30
Net Property, Plant & Equipment0.290.420.320.410.030.080.120.15
Total Investments and Advances0.000.000.000.000.000.000.000.00
Long-Term Note Receivable-----0.000.180.13
Intangible Assets2.275.337.234.502.712.632.311.44
Other Assets0.010.010.030.030.030.030.030.03
Total Assets9.539.3515.8224.6235.726.214.214.04
Short Term Debt Incl. Current Port. of LT Debt0.060.040.170.160.0012.5910.596.97
Accounts Payable5.364.203.932.460.831.790.740.70
Other Current Liabilities0.811.531.961.661.677.754.433.63
Total Current Liabilities6.235.776.054.282.5122.1415.7611.30
Long Term Debt0.210.270.030.033.4211.3511.1711.17
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.000.000.00
Total Liabilities6.446.046.084.315.9333.4926.9322.47
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value1E-060.000.000.000.000.000.000.00
Common Equity3.093.319.7420.3129.79-27.28-22.72-18.42
Total Shareholders Equity3.093.319.7420.3129.79-27.28-22.72-18.42
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity3.093.319.7420.3129.79-27.28-22.72-18.42
Total Liabilities & Stockholders Equity9.539.3515.8224.6235.726.214.214.04
Book Value Per Share14.5778.05857.931,820.272,728.95-3,323.68-2,768.16-2,244.84
Tangible Book Value Per Share3.86-47.56221.041,416.602,480.64-3,644.63-3,049.24-2,419.98
Full-Time Employees7245375594137-
Price to Book Ratio0.651.360.360.552.295.01--
Return on Assets-111.09-99.31-54.90-33.96-42.75-89.25-114.47-
Return on Equity-327.77-191.51-73.87-40.90-713.06---
Return on Invested Capital-317.79-349.12-113.61-50.38-26.98---
Quick Ratio1.120.621.364.6013.150.160.100.20
Current Ratio1.120.621.364.6013.150.160.100.20

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-11.42-10.49-12.50-11.10-10.25-8.96-4.65-4.73-5.35
Depreciation1.201.732.292.121.211.000.820.630.47
Other Funds (Non Cash)2.102.402.440.590.872.570.500.361.82
Funds from Operations-8.11-6.35-7.76-8.40-8.17-5.39-3.33-3.73-3.06
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital1.112.11-0.502.592.35-5.283.041.050.37
Cash from Operating Activities-7.00-4.24-8.26-5.81-5.82-10.67-0.29-2.68-2.69
Capital Expenditures-1.70-1.00-0.71-4.74-3.19-1.04-1.10-1.48-1.03
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.002.69-2.480.000.000.000.000.00
Purchase of Investments0.000.00-0.46-13.040.000.000.000.000.00
Sale Or Maturity of Investments0.000.003.1510.560.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-1.70-1.001.98-7.23-3.19-1.04-1.10-1.48-1.03
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock12.5310.245.820.070.0837.780.000.000.00
Repurchase of Common Pref Stock0.000.00-0.050.000.000.000.000.00-0.00
Sale of Common Pref Stock12.5310.245.870.070.0837.780.000.000.00
Proceedsfrom Stock Options12.5310.245.870.000.0037.720.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.00-3.500.972.033.083.52
Change in Long Term Debt0.000.000.000.00-3.500.470.780.000.00
Issuance of Long Term Debt0.000.000.000.000.003.470.780.000.00
Reduction of Long Term Debt0.000.000.000.00-3.50-3.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities12.5310.245.820.07-3.4238.752.033.083.53
Net Change in Cash3.835.00-0.47-12.97-12.4327.040.64-1.08-0.19
Free Cash Flow-7.00-4.24-8.32-5.83-6.03-10.67-0.29-2.71-2.75
Preferred Dividends (Cash Flow)--0.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments4.412.826.882.780.590.78
Short Term Receivables0.020.130.050.120.370.58
Inventories0.000.000.000.000.000.00
Other Current Assets0.050.530.030.700.200.16
Total Current Assets4.483.486.953.601.171.53
Net Property, Plant & Equipment0.260.280.290.330.360.39
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets2.642.842.275.064.504.91
Other Assets0.010.010.010.010.010.01
Total Assets7.396.619.539.006.036.84
Short Term Debt Incl. Current Port. of LT Debt0.060.060.060.050.050.05
Accounts Payable4.674.715.364.774.323.79
Other Current Liabilities0.740.830.810.870.811.09
Total Current Liabilities5.485.606.235.705.174.92
Long Term Debt0.180.200.210.230.240.25
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities5.665.806.445.925.415.17
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.001E-060.000.000.00
Common Equity1.740.813.093.070.621.67
Total Shareholders Equity1.740.813.093.070.621.67
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1.740.813.093.070.621.67
Total Liabilities & Stockholders Equity7.396.619.539.006.036.84
Book Value Per Share1.141.1014.5712.589.9626.73
Tangible Book Value Per Share-0.59-2.733.86-8.12-62.09-51.98
Full-Time Employees--7---
Price to Book Ratio0.655.720.714.103.931.59
Return on Assets-170.10-165.08-111.09-113.84-113.65-116.28
Return on Equity-968.47-894.59-327.77-296.20-303.74-265.37
Return on Invested Capital-71.12-225.27-151.55-84.28-121.37-86.22
Quick Ratio0.820.621.120.630.230.31
Current Ratio0.820.621.120.630.230.31

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-1.36-2.28-5.00-2.78-1.05-1.66
Depreciation0.200.140.410.460.430.43
Other Funds (Non Cash)-0.00-0.262.37-0.00-0.090.13
Funds from Operations-1.17-2.40-2.22-2.32-0.71-1.10
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.48-0.961.310.290.510.00
Cash from Operating Activities-0.69-3.36-0.92-2.04-0.19-1.10
Capital Expenditures0.00-0.700.00-1.00-0.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.00-0.700.00-1.00-0.000.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.00-0.000.000.00
Change in Capital Stock2.290.004.495.750.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock2.290.004.495.750.000.00
Proceedsfrom Stock Options2.290.004.495.750.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.52-0.52-0.000.00
Other Financing Activities Uses0.000.000.52-0.52-0.000.00
Cash from Financing Activities2.290.005.015.23-0.000.00
Net Change in Cash1.60-4.064.102.19-0.19-1.10
Free Cash Flow-0.69-3.36-0.92-2.04-0.19-1.10

Revenue breakdown

Product2024: 9.10M 2025: 1.74M
Shipping and Handling2024: 186.17K 2025: 194.00K
United States2024: 9.29M 2025: 1.93M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3012.11%0.3M2.5M709.49K
2026-10-156.30%0.2M2.5M647.36K
2026-09-306.39%0.2M2.5M669.31K
2026-09-158.76%0.2M2.5M586.35K
2026-08-315.71%0.1M2.5M237.76K
2026-08-145.94%0.1M2.5M136.72K
2026-07-3111.94%0.2M1.5M320.19K
2026-07-1512.14%0.2M1.5M668.47K
2026-06-3010.31%0.2M1.5M846.11K
2026-06-1512.69%0.2M1.4M857.10K
2026-05-2916.74%0.2M1.4M977.85K
2026-05-158.61%0.1M1.3M927.31K
2026-04-303.93%0.1M1.3M752.85K
2026-04-1518.72%0.1M0.7M409.06K
2026-03-311.97%0.0M0.7M193.04K
2026-03-1331.59%0.1M0.2M172.94K
2026-02-279.66%0.0M0.2M45.25K
2026-02-139.26%0.0M0.2M39.92K
2026-01-303.23%0.0M0.2M28.67K
2026-01-153.20%0.0M0.2M27.76K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-098-KCurrent report2026-11-05SEC
2026-11-058-KCurrent report2026-11-02SEC
2026-11-028-KCurrent report2026-10-30SEC
2026-10-30PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-30SEC
2026-10-19DEFR14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-09PRER14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-098-KCurrent report2026-10-09SEC
2026-09-14DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-10-09SEC
2026-09-108-KCurrent report2026-09-08SEC
2026-09-04PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-09-04SEC
2026-09-048-KCurrent report2026-09-04SEC
2026-08-318-KCurrent report2026-08-26SEC
2026-08-148-KCurrent report2026-08-12SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-118-KCurrent report2026-08-06SEC
2026-08-078-KCurrent report2026-08-05SEC
2026-08-07424B4SEC
2026-07-30EFFECTEffectiveness filing by commission orderSEC
2026-07-17S-1/ASEC
2026-07-148-KCurrent report2026-07-09SEC
2026-07-06S-1/ASEC
2026-06-24S-1General form of registration statement for all companies including face-amount certificate companiesSEC
2026-06-22DRS/ASEC
2026-06-17EFFECTEffectiveness filing by commission orderSEC
2026-06-15CORRESPSEC
2026-06-15UPLOADUpload SubmissionSEC
2026-06-04S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-06-04DRSSEC
2026-06-018-KCurrent report2026-05-29SEC
2026-05-298-KCurrent report2026-05-29SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
JANE STREET GROUP, LLC1.70%
StoneX Group Inc.0.64%
IFP Advisors, Inc0.57%
UBS Group AG0.55%
GEODE CAPITAL MANAGEMENT, LLC0.49%
Tower Research Capital LLC0.02%
BlackRock, Inc.0.00%
VANGUARD CAPITAL MANAGEMENT LLC0.00%
Caitong International Asset Management Co., Ltd0.00%
BARCLAYS PLC0.00%

Funds

Fund% owned
Fidelity Extended Market Index Fund0.49%
Fidelity Nasdaq Composite Index Fund0.00%
Fidelity Total Market Index Fund0.00%
VANGUARD EXTENDED MARKET INDEX FUND0.00%
Blackstone Alternative Multi-Strategy Fund-0.01%

OakChart. ISPC. Cached 15 minutes.

Some panels did not load: ratings, insider.